O
Ora Clinical | Retina Consultants of Nashville
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
RO7200220
Ranibizumab
Vamikibart
Parent organization
This site is a part of Ora Clinical
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 2 total trials
A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD
This study will compare the efficacy and safety of HLX04-O administered by intravitreal injection (IVT) with ranibizumab in patients with active wAMD.
Active, not recruiting
Age Related Macular Degeneration
Drug: HLX04-O
Drug: ranibizumab
Study BP43445 is a phase II, multicenter, randomized, double-masked, active comparator-controlled study to investigate the efficacy, safety, tolerabi...
Active, not recruiting
Diabetic Macular Edema
Drug: Ranibizumab
Other: Sham Procedure
Trial sponsors
H
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems